Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The company is committed to improving patient welfare and outcomes, increasing clinical data accuracy, and promoting positive health economics.
Observe Medical is listed on Euronext Oslo under OBSRV.
Observe Medical ASA (the "Company") has on November 11, 2022, granted 1,000,000 share options in the Company to the group CEO, Rune Nystad. The options have been granted with an exercise price of NOK 4.5 per option share. The options will west in three tranches, whereby each tranche comprising 1/3 of the options will vest…
Read moreOslo, 3 November 2022 – Observe Medical ASA (“the Company” or “Observe Medical”) today release its results for the third quarter of 2022. "In October, we announced that Observe Medical had entered into an exclusive agreement with the intention to acquire Convatec’s Unometer urine measurement portfolio, consisting of several market-leading brand names such as Unometer™…
Read moreObserve Medical aims for a transformative acquisition to become the leading urine measurement system provider Oslo, 21 October 2022 – Observe Medical ASA ("Observe Medical" or "the Company" and together with its subsidiary "the Group") has entered into an exclusive agreement with the intention to acquire the rights to own, produce and sell an extensive…
Read moreAs at 1 November 2022
| Name | Number of shares | % of top 20 | % of total | Country | ||
|---|---|---|---|---|---|---|
| 1 | INGERØ REITEN INVESTMENT COMPANY AS | 9,653,680 | 28.07% | 18.05% | Norway | |
| 2 | NAVAMEDIC ASA | 4,222,727 | 12.28% | 7.89% | Norway | |
| 3 | RO, LARS | 3,033,303 | 8.82% | 5.67% | Norway | |
| 4 | JPB AS | 2,830,209 | 8.23% | 5.29% | Norway | |
| 5 | ELI AS | 2,178,078 | 6.33% | 4.07% | Norway | |
| 6 | NORDA ASA | 1,874,917 | 5.45% | 3.51% | Norway | |
| 7 | MP PENSJON PK | 1,701,188 | 4.95% | 3.18% | Norway | |
| 8 | UBS Switzerland AG | 1,445,547 | 4.20% | 2.70% | Switzerland | |
| 9 | DNB BANK ASA | 1,180,400 | 3.43% | 2.21% | Norway | |
| 10 | LAPAS AS | 805,185 | 2.34% | 1.51% | Norway | |
| 11 | BJØRNTVEDT, VEGARD | 686,238 | 2.00% | 1.28% | Norway | |
| 12 | SOLEGLAD INVEST AS | 586,668 | 1.71% | 1.10% | Norway | |
| 13 | SILVERCOIN INDUSTRIES AS | 574,464 | 1.67% | 1.07% | Norway | |
| 14 | Nordnet Bank AB | 554,499 | 1.61% | 1.04% | Sweden | |
| 15 | HIMALAYA TANDORI AS | 550,000 | 1.60% | 1.03% | Norway | |
| 16 | NORDNET LIVSFORSIKRING AS | 534,128 | 1.55% | 1.00% | Norway | |
| 17 | TAJ HOLDING AS | 500,847 | 1.46% | 0.94% | Norway | |
| 18 | GINNY INVEST AS | 500,000 | 1.45% | 0.93% | Norway | |
| 19 | TRANBERGKOLLEN INVEST AS | 500,000 | 1.45% | 0.93% | Norway | |
| 20 | BRØDRENE KARLSEN HOLDING AS | 479,868 | 1.40% | 0.90% | Norway | |
| Total number owned by top 20 | 34,391,946 | 100.00% | 64.29% | |||
| Total number of shares | 53,491,656 |
Stock Exchange:
Ticker:
First day of listing:
Sector:
Trading Currency:
ISIN:
Number of shares issued:
Nominal value:
Euronext Expand Oslo
OBSRV
4 November 2019
Healthcare
NOK
NO0010865009
53 491 656
NOK 0.26
The Articles of Association provide for a nomination committee composed of two or three members. The current members of the nomination committee are Bård Brath Ingerø (chair) and Grete Hogstad.
The nomination committee is responsible for nominating candidates for the election of shareholder-elected members and chairperson to the Board of Directors and for nominating members to the nomination committee, as well as making recommendations for remuneration of these.
For nomination committee please contact:
Bård Brath Ingerø, Chair of the Nomination Committee
+47 92 83 33 34 / bbi@reitenco.no
3 June 2022: Minutes from Annual General Meeting 2022
3 June 2022: Represented list
31 May 2022: Board of Directors recommendation for appointment of auditor
31 May 2022: The Nomination Committee recommendation part 2
13 May 2022: Notice of Annual General Meeting on 3 June 2022
13 May 2022: Notice of attendance and proxy form to the Annual General Meeting on 3 June 2022
13 May 2022: The Nomination Committee’s recommendation (part 1)
13 May 2022: Guidelines for determination of salary and other remuneration to executive personnel
13 May 2022: Report on salary and other remuneration to executive personnel year 2021
13 May 2022: VPS – Investor services
13 May 2022: LUMI
13 May 2022: Online guide LUMI (Norsk)
13 May 2022: Online guide LUMI (English)
4 February 2022: Minutes from Extraordinary General Meeting
4 February 2022: Represented list
14 January 2022: Notice of Extraordinary General Meeting on 4 February 2022
14 January 2022: Notice of attendance and proxy form to the Extraordinary General Meeting on 4 February 2022
21 May 2021: Minutes from Annual General meeting
30 April 2021: Notice of Annual General Meeting on 21 May 2021
30 April 2021: Notice of attendance and proxy form to the Annual General meeting on 21 May 2021
30 April 2021: The Nomination Committee's recommendation
30 April 2021: Guidelines for determination of salary and other remuneration to executive Personnel
30 June 2020: Annual General Meeting
16 June 2020: Extraordinary General Meeting
9 June 2020: Notice of Annual General Meeting on 30 June 2020
9 June 2020: Attendance to the Annual General Meeting on 30 June 2020
9 June 2020: Recommendation by the Nomination Committee
9 June 2020: The Boards declaration on remuneration to executive management
26 May 2020: Notice of Extraordinary General Meeting on 16 June 2020
26 May 2020: Attendance to the Extraordinary General Meeting on 16 June 2020
24 October 2019: Extraordinary General Meeting
1 October 2019: Extraordinary General Meeting
5 August 2019: Extraordinary General Meeting
Rune Nystad, Chief Executive Officer +47 91 62 46 83 / rune.nystad@observemedical.com
Per Arne Nygård, Chief Financial Officer +47 41 10 43 45 / perarne.nygard@observemedical.com